These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35414424)

  • 1. Patients After Orthotopic Heart Transplantation With COVID-19: Are We Fast Enough With Vaccinations?
    Kuczaj A; Przybyłowski P
    Transplant Proc; 2022 May; 54(4):897-900. PubMed ID: 35414424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic Status According Severe Acute Respiratory Syndrome Coronavirus 2 in Patients After Orthotopic Heart Transplantation.
    Kuczaj A; Przybyłowski P
    Transplant Proc; 2022 May; 54(4):901-904. PubMed ID: 35414422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients - a prospective cohort study.
    Itzhaki Ben Zadok O; Shaul AA; Ben-Avraham B; Yaari V; Ben Zvi H; Shostak Y; Pertzov B; Eliakim-Raz N; Abed G; Abuhazira M; Barac YD; Mats I; Kramer MR; Aravot D; Kornowski R; Ben-Gal T
    Eur J Heart Fail; 2021 Sep; 23(9):1555-1559. PubMed ID: 33963635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients.
    Itzhaki Ben Zadok O; Shaul AA; Ben-Avraham B; Yaari V; Ben Zvi H; Eliakim-Raz N; Yahav D; Abed G; Abuhazira M; Barac YD; Mats I; Shochat T; Aravot D; Kornowski R; Ben-Gal T
    ESC Heart Fail; 2022 Apr; 9(2):905-911. PubMed ID: 34981657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report.
    Spinner JA; Julien CL; Olayinka L; Dreyer WJ; Bocchini CE; Munoz FM; Devaraj S
    J Heart Lung Transplant; 2022 Feb; 41(2):133-136. PubMed ID: 34911654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels.
    Mohr-Sasson A; Haas J; Abuhasira S; Sivan M; Doitch Amdurski H; Dadon T; Blumenfeld S; Derazne E; Hemi R; Orvieto R; Afek A; Rabinovici J
    Hum Reprod; 2022 Mar; 37(3):534-541. PubMed ID: 34935913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination.
    Moon AM; Webb GJ; García-Juárez I; Kulkarni AV; Adali G; Wong DK; Lusina B; Dalekos GN; Masson S; Shore BM; Barnes E; Barritt AS; Marjot T
    Hepatol Commun; 2022 Apr; 6(4):889-897. PubMed ID: 34708575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccines in Pancreatic Transplant Recipients: A Single-Center Observative Study.
    Matejak-Górska M; Zielonka M; Górska H; Durlik M
    Transplant Proc; 2022 May; 54(4):925-929. PubMed ID: 35437149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients.
    Shaul AA; Itzhaki Ben Zadok O; Ben-Avraham B; Yaari V; Barsheshet A; Levi A; Ben Zvi H; Eliakim Raz N; Abed G; Abuhazira M; Abu Akel M; Mats I; Barac YD; Aravot D; Kornowski R; Ben-Gal T
    Eur J Cardiothorac Surg; 2022 Sep; 62(4):. PubMed ID: 35244690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predictive of anti-spike antibody titers after COVID-19 vaccination in hemodialysis patients.
    Aoun M; Kahwaji RM; Sleilaty G; Boueri C; Hawi J; Khalil CB; Hage V
    Adv Clin Exp Med; 2022 Aug; 31(8):855-861. PubMed ID: 35438849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
    Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
    Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre.
    Oehler D; Bruno RR; Boeken U; Westenfeld R
    Transpl Infect Dis; 2021 Aug; 23(4):e13681. PubMed ID: 34216078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.